Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer

SIMPLE SUMMARY: Patients with lung cancer benefit from more effective treatments, such as targeted therapies, and the overall survival has increased in the past decade. However, the efficacy of targeted therapies is limited due to the emergence of resistance. Growing evidence suggests that resistanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Delahaye, Celia, Figarol, Sarah, Pradines, Anne, Favre, Gilles, Mazieres, Julien, Calvayrac, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179469/
https://www.ncbi.nlm.nih.gov/pubmed/35681591
http://dx.doi.org/10.3390/cancers14112613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179469/
https://www.ncbi.nlm.nih.gov/pubmed/35681591
http://dx.doi.org/10.3390/cancers14112613

Ejemplares similares